Among the biologics studied, Benralizumab showed a trend toward significance, with higher adherence associated with fewer ED visits.
← all excerpts
The Impact of Biological Therapies and the Significance of Their Adherence on Asthma Outcomes in a Single Tertiary Asthma Center.
1
—
—